SLNO has been in the news 563% more than usual
Mar 12, 2026, 10:32 AM
1.10%
What does SLNO do
Soleno Therapeutics, a clinical-stage biopharmaceutical company based in Redwood City, California, focuses on developing novel therapeutics for rare diseases, notably DCCR for Prader-Willi syndrome. DCCR, a once-daily oral tablet, recently completed Phase 3 trials and has received Fast-Track and orphan designations in the U.S. and EU.
SLNO has been in the news recently: A class action lawsuit has been filed against Soleno Therapeutics, Inc. for alleged violations of securities laws related to misleading statements made from March 26 to November 4, 2025, after the company's stock dropped by 26% following a disappointing report on DCCR. Both the Schall Law Firm and the DJS Law Group are encouraging investors to participate in this lawsuit.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.